Parati G, Mancia G
Centro di Fisiologia Clinica e Ipertensione, Ospedale Maggiore, Cattedra di Medicina Interna, Milano, Italy.
Am Heart J. 1993 Feb;125(2 Pt 2):642-8. doi: 10.1016/0002-8703(93)90216-v.
Calcium antagonists are widely used antihypertensive agents whose hemodynamic effects consist of a reduction in blood pressure and peripheral vascular resistance that is associated, in case of short-term administration, with a reflex increase in heart rate and cardiac output. These compounds exert several additional positive effects besides blood pressure reduction. Among them, calcium antagonists exert their antihypertensive effect without negatively interfering with both central and reflex neural control of circulation. The only change in baroreflex function observed during the administration of these compounds is a resetting of the baroreflex toward the lower blood pressure values achieved by treatment. New calcium antagonists of the dihydropyridine type are characterized by a greater vascular selectivity, and by the ability to exert a persistent blood pressure reduction throughout the 24 hours when administered in a single oral dose. The latter feature can be properly assessed by means of ambulatory blood pressure monitoring techniques.
钙拮抗剂是广泛使用的抗高血压药物,其血流动力学效应包括血压降低和外周血管阻力降低。在短期给药的情况下,这与心率和心输出量的反射性增加有关。这些化合物除了降低血压外,还具有其他几种积极作用。其中,钙拮抗剂在不负面影响中枢和反射性神经循环控制的情况下发挥其抗高血压作用。在使用这些化合物期间观察到的压力反射功能的唯一变化是压力反射朝着治疗所达到的较低血压值重新设定。新型二氢吡啶类钙拮抗剂的特点是具有更高的血管选择性,并且在单次口服给药时能够在24小时内持续降低血压。后一特性可以通过动态血压监测技术进行适当评估。